Federal Register #2026-20115

DEA Seeks Comments on Pharmacy Records for Transferred Electronic Prescriptions

The Drug Enforcement Administration is seeking public comments on pharmacy recordkeeping for transferred electronic prescriptions, not soliciting products or services. - Government buyer: Drug Enforcement Administration (DEA), U.S. Department of Justice (DOJ). - Requested action: Comments on extending an existing information collection related to transfers of electronic prescriptions for controlled substances in Schedules III–V. - Recordkeeping requirement: Both the transferring and receiving pharmacies must update the electronic prescription record with the other pharmacy’s name, address, and DEA registration number; the names of the pharmacists involved; and the transfer date. - OEMs and vendors: None named. No products, quantities, or procurement services are requested. - Authorization period: DOJ seeks a three-year extension of the information-collection authorization.

Description

The Drug Enforcement Administration, Department of Justice, is seeking review and approval from the Office of Management and Budget for a previously approved information collection under the Paperwork Reduction Act. The collection requires pharmacies transferring electronic prescriptions in Schedules III–V to update prescription records with transfer details, including the pharmacies’ identifying information, the pharmacists’ names, and the transfer date. Comments are requested by November 2, 2026.

View original listing